Ledger.Open graph →
SEC Form D · filed November 9, 2018

RITTER PHARMACEUTICALS INC

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Noah E. Doyle · Los Angeles, CADirectorIra E. Ritter · Los Angeles, CAExec · DirectorJohn W. Beck · Los Angeles, CAExecAndrew J. Ritter · LOS ANGELES, CAExec · DirectorWilliam M. Merino · Los Angeles, CADirectorMichael D. Step · Los Angeles, CADirectorMatthew W. Foehr · LA JOLLA, CADirectorPaul V. Maier · Los Angeles, CADirectorIra E. Ritter · Los Angeles, CAExec · DirectorJohn W. Beck · Los Angeles, CAExecAndrew J. Ritter · Los Angeles, CAExec · DirectorNoah E. Doyle · Los Angeles, CADirectorWilliam M. Merino · Los Angeles, CADirectorMichael D. Step · Los Angeles, CADirectorMatthew W. Foehr · LA JOLLA, CADirectorPaul V. Maier · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗